Earnings ·
Reports Q3 GAAP revenue of $253.7 million, up 177% year-over-year
VREOFVireo Growth Inc.
Vireo Growth Inc. reported third-quarter GAAP revenue of $253.7 million, a 177% increase from the prior-year period, driven by recent acquisitions including PharmaCann Colorado and C21 Investments. Adjusted EBITDA reached $42.7 million, up 68.1% year-over-year. The company closed the quarter with $106.8 million in cash and announced a $60.0 million real estate term loan subsequent to period-end. Vireo also provided Q4 2026 revenue guidance of $250 million to $265 million and Adjusted EBITDA guidance of $45 million to $48 million, while noting an annualized revenue run rate exceeding $1 billion. The company operates as a vertically integrated cannabis and agricultural markets platform across the United States.